Viewing Study NCT05981235


Ignite Creation Date: 2025-12-24 @ 10:44 PM
Ignite Modification Date: 2026-03-08 @ 1:58 AM
Study NCT ID: NCT05981235
Status: COMPLETED
Last Update Posted: 2025-07-31
First Post: 2023-08-01
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Trial of AZD6422 in CLDN18.2+ GI Tumors
Sponsor: Peking University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gastrointestinal Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CLDN18.2+ GI Tumors Solid tumor CAR-T Cell therapy AZD6422 View